EMT and Anti-EMT Strategies in Cancer


This article discusses the role of epithelial mesenchymal transition (EMT) and addresses the scientific merits on epigenetic regulation of EMT. The importance of EMT as a prognostic biomarker is explored and the rationale on application of multitargeted epigenetic therapy is discussed. We describe a literature review of the epigenetic influence of such process and we present a potentially effective method to reverse the epigenetic switch in favor for MET, in a clinical setting. A case series of advanced solid tumors are summarized aiming at generating hypothesis for the future recommendations for clinical trials targeting the tumor’s biological behavior through inhibition of EMT. Hypothesis: We propose an integral and integrative approach that can modify tumor’s biological behavior through inhibition of EMT, and further reduce the chances of metastasis, that can translate to improved outcome and patient’s survival in advanced disease.

Share and Cite:

Nezami, M. , Hager, S. and Garner, J. (2015) EMT and Anti-EMT Strategies in Cancer. Journal of Cancer Therapy, 6, 1013-1019. doi: 10.4236/jct.2015.611110.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Vija, L., Farge, D., Gautier, J., Vexiau, P. and Dumitrache, C. (2008) Mesenchymal Stem Cells: Stem Cell Therapy Perspectives for Type 1 Diabetes. Diabetes & Metabolism, 2015, 85-93.
[2] Nakaya, Y. and Sheng, G.J. (2013) EMT in Developmental Morphogenesis. Cancer Letters, 341, 9-15.
[3] Kalluri, R. and Weinberg, R.A. (2009) The Basics of Epithelial-Mesenchymal Transition. Journal of Clinical Investigation, 119, 1420-1428.
[4] Wang, Z., Li, Y., Ahmad, A., Azmi, A., Kong, D. and Banerjee, S. (2010) Targeting miRNAs Involved in Cancer Stem Cell and EMT Regulation: An Emerging Concept in Overcoming Drug Resistance. Drug Resistance Updates, 13, 109-118.
[5] Ivanova, T., Zouridis, H., Wu, Y., Cheng, L., Tan, I. and Gopalakrishnan, V. (2012) Integrated Epigenomics Identifies BMP4 as a Modulator of Cisplatin Sensitivity in Gastric Cancer. Gut, 62, 22-33.
[6] Neureiter, D. (2012) Epigenetic Control of Epithelial-Mesenchymal-Transition in Human Cancer (Review). Molecular and Clinical Oncology, 2, 3-11.
[7] Liu, X. and Fan, D. (2015) The Epithelial-Mesenchymal Transition and Cancer Stem Cells: Functional and Mechanistic Links. Current Pharmaceutical Design, 21, 1279-1291.
[8] Peinado, H., Olmeda, D. and Cano, A. (2007) Snail, Zeb and bHLH Factors in Tumour Progression: An Alliance against the Epithelial Phenotype? Nature Reviews Cancer Nat Rev Cancer, 7, 415-428.
[9] Yang, J. and Weinberg, R. (2008) Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis. Developmental Cell, 14, 818-829.
[10] Kurrey, N., Jalgaonkar, S., Joglekar, A., Ghanate, A., Chaskar, P., Doiphode, R. and Bapat, S. (2009) Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells. Stem Cells, 27, 2059-2068.
[11] Vlahopoulos, S., Logotheti, S., Mikas, D., Giarika, A., Gorgoulis, V., et al. (2008) The Role of ATF-2 in Oncogenesis. BioEssays, 30, 314-327.
[12] Huber, M., Beug, H. and Wirth, T. (2004) Epithelial-Mesenchymal Transition: NF-κB Takes Center Stage. Cell Cycle, 3, 1477-1480.
[13] Katoh, Y. and Katoh, M. (2008) Hedgehog Signaling, Epithelial-to-Mesenchymal Transition and miRNA (Review). International Journal of Molecular Medicine, 22, 271-275.
[14] Fuxe, J. and Karlsson, M. (2012) TGF-β-Induced Epithelial-Mesenchymal Transition: A Link between Cancer and Inflammation. Seminars in Cancer Biology, 22, 455-461.
[15] Zhang, J.Y., Tian, X.J., Zhang, H., Teng, Y., Li, R.Y., Bai, F., Elankumaran, S. and Xing, J.H. (2014) TGF-β-Induced Epithelial-to-Mesenchymal Transition Proceeds through Stepwise Activation of Multiple Feedback Loops. Science Signaling, 7, ra91.
[16] Cui, S.Y., Wang, R. and Chen, L.B. (2013) MicroRNAs: Key Players of Taxane Resistance and Their Therapeutic Potential in Human Cancers. Journal of Cellular and Molecular Medicine, 17, 1207-1217.
[17] Lee, J.G. and Kay, E.P. (2006) FGF-2-Mediated Signal Transduction during Endothelial Mesenchymal Transformation in Corneal Endothelial Cells. Experimental Eye Research, 83, 1309-1316.
[18] Herfs, M., Hubert, P., Suarez-Carmona, M., Reschner, A., Saussez, S., Berx, G., Savagner, P., Boniver, J. and Delvenne, P. (2010) Regulation of p63 Isoforms by Snail and Slug Transcription Factors in Human Squamous Cell Carcinoma. The American Journal of Pathology, 176, 1941-1949.
[19] Chakrabarti, R., Hwang, J., Blanco, M., Wei, Y., Lukacisin, M., et al. (2012) Elf5 Inhibits the Epithelial-Mesenchymal Transition in Mammary Gland Development and Breast Cancer Metastasis by Transcriptionally Repressing Snail2. Nature Cell Biology, 14, 1212-1222.
[20] Savagner, P. (2010) The Epithelial-Mesenchymal Transition (EMT) Phenomenon. Annals of Oncology, 21, Vii89-Vii92.
[21] Savagner, P., Yamada, K.M. and Thiery, J.P. (1997) The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor-Induced Epithelial-Mesenchymal Transition. The Journal of Cell Biology, 137, 1403-1419.
[22] Lindsay, J., Mcdade, S., Pickard, A., Mccloskey, K. and Mccance, D. (2010) Role of ΔNp63γ in Epithelial to Mesenchymal Transition. Journal of Biological Chemistry, 286, 3915-3924.
[23] Boldrup, L., Coates, P., Gu, X. and Nylander, K. (2007) ΔNp63 Isoforms Regulate CD44 and Keratins 4, 6, 14 and 19 in Squamous Cell Carcinoma of Head and Neck. The Journal of Pathology, 213, 384-391.
[24] Firdous, A., Sharmila, G., Balakrishnan, S., Rajasingh, P., Suganya, S., et al. (2014) Quercetin, a Natural Dietary Flavonoid, Acts as a Chemopreventive Agent against Prostate Cancer in an in Vivo Model by Inhibiting the EGFR Signaling Pathway. Food & Function, 5, 2632-2645.
[25] Kang, Y.B., He, W., Tulley, S., Gupta, G.P., Serganova, I., Chen, C.-R., Manova-Todorova, K., Blasberg, R., Gerald, W.L. and Massagué, J. (2005) Breast Cancer Bone Metastasis Mediated by the Smad Tumor Suppressor Pathway. Proceedings of the National Academy of Sciences of the United States of America, 102, 13909-13914.
[26] Pachmann, K., Camara, O., Kavallaris, A., Krauspe, S., Malarski, N., Gajda, M., et al. (2008) Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse. Journal of Clinical Oncology, 26, 1208-1215.
[27] Chang, C.-J., Chao, C.-H., Xia, W.Y., Yang, J.-Y., Xiong, Y., Li, C.-W., Yu, W.-H., Rehman, S.K., Hsu, J.L., Lee, H.-H., Liu, M., Chen, C.-T., Yu, D.H. and Hung, M.-C. (2011) P53 Regulates Epithelial-Mesenchymal Transition and Stem Cell Properties through Modulating miRNAs. Nature Cell Biology, 13, 317-323.
[28] Lu, M., Jolly, M., Levine, H., Onuchic, J. and Ben-Jacob, E. (2013) MicroRNA-Based Regulation of Epithelial-Hybrid-Mesenchymal Fate Determination. Proceedings of the National Academy of Sciences of the United States of America, 110, 18144-18149.
[29] Craene, B. and Berx, G. (2013) Regulatory Networks Defining EMT during Cancer Initiation and Progression. Nature Reviews Cancer, 13, 97-110.
[30] Grange, C., Collino, F., Tapparo, M. and Camussi, G. (2014) Oncogenic Micro-RNAs and Renal Cell Carcinoma. Frontiers in Oncology, 4, 49.
[31] Huangyang, P.W. and Shang, Y.F. (2013) Epigenetic Regulation of Epithelial to Mesenchymal Transition. Current Cancer Drug Targets, 13, 973-985.
[32] Tian, X.J., Zhang, H. and Xing, J.H. (2013) Coupled Reversible and Irreversible Bistable Switches Underlying TGFβ-Induced Epithelial to Mesenchymal Transition. Biophysical Journal, 105, 1079-1089.
[33] Wang, Y. and Shang, Y.F. (2013) Epigenetic Control of Epithelial-to-Mesenchymal Transition and Cancer Metastasis. Experimental Cell Research, 319, 160-169.
[34] Micalizzi, D., Farabaugh, S.M. and Ford, H.L. (2010) Epithelial-Mesenchymal Transition in Cancer: Parallels between Normal Development and Tumor Progression. Journal of Mammary Gland Biology and Neoplasia, 15, 117-134.
[35] Chang, Y.C., Chen, P.N., Chu, S.C., Lin, C.Y., Kuo, W.H., et al. (2012) Black Tea Polyphenols Reverse Epithelial-to-Mesenchymal Transition and Suppress Cancer Invasion and Proteases in Human Oral Cancer Cells. Journal of Agricultural and Food Chemistry, 60, 8395-8403.
[36] Lin, C.H., Shen, Y.A., Hung, P.H., Yu, Y.B. and Chen, Y.J. (2012) Epigallocathechin Gallate, Polyphenol Present in Green Tea, Inhibits Stem-Like Characteristics and Epithelial-Mesenchymal Transition in Nasopharyngeal Cancer Cell Lines. BMC Complementary and Alternative Medicine, 12, 201.
[37] Belguise, K., Guo, S., Yang, S., Rogers, A., Seldin, D., et al. (2007) Green Tea Polyphenols Reverse Cooperation between c-Rel and CK2 That Induces the Aryl Hydrocarbon Receptor, Slug, and an Invasive Phenotype. Cancer Research, 67, 11742-11750.
[38] Tang, S.N., Singh, C., Nall, D., Meeker, D., Shankar, S., et al. (2010) The Dietary Bioflavonoid Quercetin Synergizes with Epigallocathechin Gallate (EGCG) to Inhibit Prostate Cancer Stem Cell Characteristics, Invasion, Migration and Epithelial-Mesenchymal Transition. Journal of Molecular Signaling, 5, 14.
[39] Lu, Q., Ji, X.J., Zhou, Y.X., Yao, X.Q., Liu, Y.Q., et al. (2015) Quercetin Inhibits the mTORC1/p70S6K Signaling-Mediated Renal Tubular Epithelial-Mesenchymal Transition and Renal Fibrosis in Diabetic Nephropathy. Pharmacological Research, 99, 237-247.
[40] Bhat, F., Sharmila, G., Balakrishnan, S., Arunkumar, R., Elumalai, P., et al. (2014) Quercetin Reverses EGF-Induced Epithelial to Mesenchymal Transition and Invasiveness in Prostate Cancer (PC-3) Cell Line via EGFR/PI3K/Akt Pathway. The Journal of Nutritional Biochemistry, 25, 1132-1139.
[41] Fantozzi, A., Gruber, D., Pisarsky, L., Heck, C., Kunita, A., Yilmaz, M., Meyer-Schaller, N., Cornille, K., Hopfer, U. Bentires-Alj, M. and Christofori, G. (2014) VEGF-Mediated Angiogenesis Links EMT-Induced Cancer Stemness to Tumor Initiation. Cancer Research, 74, 1566-1575.
[42] Liao, G., Wang, M., Ou, Y. and Zhao, Y. (2013) IGF-1-Induced Epithelial-Mesenchymal Transition in MCF-7 Cells Is Mediated by MUC1. Cellular Signalling, 26, 2131-2137.
[43] Kumar, R., Musiyenko, A. and Barik, S. (2003) The Heat Shock Protein 90 of Plasmodium Falciparum and Antimalarial Activity of Its Inhibitor, Geldanamycin. Malaria Journal, 2, 30.
[44] Bukhsh, M., Speyer, C., Hachem, A., Nassar, M., Assi, A. and Gorski, D. (2014) Abstract 4608: Exploring Anti-Oncogenic Properties of Riluzole in Breast Cancer. Cancer Research, 74, 4608.
[45] Corkery, B., Crown, J., Clynes, M. and O’donovan, N. (2009) Epidermal Growth Factor Receptor as a Potential Therapeutic Target in Triple-Negative Breast Cancer. Annals of Oncology, 20, 862-867.
[46] Avan, A., Quint, K., Nicolini, F., Funel, N., Frampton, A., Maftouh, M., Pelliccioni, S., Schuurhuis, G.J., Peters, G.J. and Giovannetti, E. (2013) Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer. Current Pharmaceutical Design, 19, 940-950.
[47] Chen, W., Wang, G.M., Liu, Y.J. and Qian, R.Z. (2007) Cancer Stem-Like Cells in Human Prostate Carcinoma Cells DU145: The Seeds of the Cell Line? Cancer Biology & Therapy, 6, 763-768.
[48] Grasso, S., Tristante, E., Saceda, M., Carbonell, P., Mayor-López, L., Carballo-Santana, M., Carrasco-García, E., Rocamora-Reverte, L., García-Morales, P., Carballo, F., Ferragut, J.A., Martínez-Lacaci, I. (2014) Resistance to Selumetinib (AZD6244) in Colorectal Cancer Cell Lines Is Mediated by p70S6K and RPS6 Activation. Neoplasia, 16, 845-860.
[49] Honjo, S., Ajani, J., Scott, A., Chen, Q. and Skinner, H. (2014) Metformin Sensitizes Chemotherapy by Targeting Cancer Stem Cells and the mTOR Pathway in Esophageal Cancer. International Journal of Oncology, 45, 567-574.
[50] Bocca, C., Bozzo, F., Cannito, S., Parola, M. and Miglietta, A. (2011) Celecoxib Inactivates Epithelial-Mesenchymal Transition Stimulated by Hypoxia and/or Epidermal Growth Factor in Colon Cancer Cells. Molecular Carcinogenesis, 51, 783-795.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.